English | 简体中文 | 繁體中文 | 한국어 Home | About us | Services | Partners | Events | Contact us | Login Wednesday, April 09, 2025 3:28:51 PM  All Press Releases Language: All English Indonesian Japanese Korean Thai Trad. Chinese Simp. Chinese Vietnamese  Medicine BioTech 新版国家医保药品目录落地 全球首个IgA肾病对因治疗药物耐赋康(R)纳入报销 Jan 02, 2025 10:48 HKT Everest Medicines Announces the First Prescription of VELSIPITY(R) in the Greater Bay Area Dec 18, 2024 14:29 HKT 云顶新耀宣布伊曲莫德（VELSIPITY(R)）大湾区内地首张处方在佛山正式落地 Dec 18, 2024 14:20 HKT 雲頂新耀宣佈伊曲莫德（VELSIPITY(R)）大灣區內地首張處方在佛山正式落地 Dec 18, 2024 14:20 HKT Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY Dec 17, 2024 10:58 HKT 雲頂新耀宣佈中國國家藥品監督管理局正式受理伊曲莫德（VELSIPITY(R)） Dec 17, 2024 10:53 HKT 云顶新耀宣布中国国家药品监督管理局正式受理伊曲莫德（VELSIPITY(R)） Dec 17, 2024 10:47 HKT CIL Announces Breakthrough in Benzene Recovery, Addressing Cost, Environmental, and Supply Challenges for OLED Display Manufacturers Dec 12, 2024 22:00 HKT Everest Medicines Announces the First Prescription of VELSIPITY(R) Issued in Macau Dec 12, 2024 12:11 HKT 雲頂新耀宣佈伊曲莫德（VELSIPITY(R)）在中國澳門的首張處方落地 Dec 12, 2024 12:02 HKT 云顶新耀宣布伊曲莫德（VELSIPITY(R)）在中国澳门的首张处方落地 Dec 12, 2024 11:47 HKT Everest Medicines: Accelerating Innovation in Renal Disease to Forge a Path Toward Biopharma Leadership Dec 11, 2024 11:06 HKT 雲頂新耀：加速腎病領域創新 邁向全球生物製藥領先地位 Dec 11, 2024 11:02 HKT 云顶新耀：加速肾病领域创新 迈向全球生物制药领先地位 Dec 11, 2024 10:56 HKT VisiRose Introduces Revolutionary Therapy for Severe Eye Infections Dec 10, 2024 20:30 HKT Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy Dec 04, 2024 11:08 HKT 雲頂新耀宣佈治療原發性膜性腎病的新型BTK抑制劑EVER001在1b/2a期臨床試驗階段性數據中取得積極結果 Dec 04, 2024 10:59 HKT 云顶新耀宣布治疗原发性膜性肾病的新型BTK抑制剂EVER001在1b/2a期临床试验阶段性数据中取得积极结果 Dec 04, 2024 10:48 HKT 康哲藥業獲得治療痛風及高尿酸血症的1類新藥獨家商業化權利 Dec 02, 2024 20:49 HKT Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong Dec 02, 2024 10:34 HKT << Previous  Next >>  Releases By Industry Business ASEAN Daily News Government HR Local Biz SMEs Startups Trade Show Communications Advertising Broadcast, Film & Sat Media & Marketing Telecoms Wireless & Mobility CryptoCurrency Blockchain Technology Crypto, Exchange ICO Metaverse, Games Mining & Staking NFTs Financial Banking & Insurance Cards & Payments Daily Finance Exchanges & Software FinTech Funds & Equities Legal & Compliance Venture Capital & PE Real Estate & REIT Trade Finance Industrial Aerospace & Defence Airlines Automotive Chemical General Construct, Engineering Cosmetics, Spec.Chem Food & Beverages Manufacturing Marine & Offshore Metals & Mining Oil & Gas Print & Package Transport & Logistics Lifestyle Design & Art Beauty & Skin Care Boating Education Gaming Fashion & Apparel Hospitality Motorsports Regional, Lifestyle Retail & eCommerce Sports Travel & Tourism Watches & Jewelry Medicine BioTech Cannabis Clinical Trials Healthcare & Pharm MedTech Sustainablity Agritech Alternative Energy Energy Environment, ESG EVs, Transportation Smart Cities Water Technology Artificial Intel [AI] Automation [IoT] Cloud & Enterprise CyberSecurity Digital Drones Electronics Engineering Science & Nanotech Copyright © 2025 ACN Newswire - Asia Corporate News Network Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575 Connect With us: